This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Zr (Zirconium-89) -labelled anti-KLH human IgG and its metabolites to confirm their non-specific/physiological accumulation in healthy cynomolgus macaques. The anti-KLH antibody was used as a negative control, ensuring that the observed distribution reflected general IgG behavior rather than antigen-specific accumulation. This provides a valuable reference for comparing the biodistribution of targeted antibodies. METHODS: Zr- labelled IgG, was also assessed. RESULTS: Zr]Zr-oxalate was highly accumulated in the epiphysis of the long bones and vertebral body. CONCLUSION: Zr- labelled IgG.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sasaki et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: